Chien-Liang Liu

Chien-Liang Liu

Auto-generated profile, based on publicly available information

Chien-Liang Liu

Taipei City Hospital, Taipei Taiwan

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2021 in International Journal of Hyperthermia
Verified
Journal Article
Open access
CKChi-Yu Kuo
Chi-Yu Kuo
CLChien-Liang Liu
Chien-Liang Liu
CTChung-Hsin Tsai
Chung-Hsin Tsai
SCShih-Ping Cheng
Shih-Ping Cheng
Radiofrequency ablation (RFA) has been increasingly accepted as an alternative to surgery in the treatment of symptomatic benign thyroid nodules. However, the learning curve of thyroid RFA has yet ...

18 June 2008 in Planta Medica
Verified
Journal Article
Closed access
PDF file
Ming-Yi ShenMing-Yi Shen
Ming-Yi Shen
CLChien-Liang Liu
Chien-Liang Liu
GHGeroge Hsiao
Geroge Hsiao
CLChiung-Yueh Liu
Chiung-Yueh Liu
KLKuang-Hung Lin
Kuang-Hung Lin
Joen-Rong SheuJoen-Rong Sheu
Joen-Rong Sheu
Aristolochic acid (AsA) is produced from Aristolochia fangchi, and has been used as a Chinese herbal medicine. AsA possesses various biological activities including antiplatelet, antifungal, and anti-inflammatory properties. The aim of this study was to examine the mechanisms of AsA in inhibiting platelet aggregation. AsA (75 – 150 μM) exhibited more-potent activity of inhibiting platelet aggregation stimulated by collagen (1 μg/mL) than other agonists. AsA (115 and 150 μM) inhibited collagen-induced platelet activation accompanied by [Ca+ 2]i mobilization, thromboxane A2 (TxA2) formation and phosphoinositide breakdown. On the other hand, AsA also markedly increased levels of NO/cyclic GMP, and cyclic GMP-induced vasodilator-stimulated phosphoprotein phosphorylation. AsA inhibited p38 MAPK but not ERK1/2 phosphorylation in washed platelets. In conclusion, the most important findings of this study suggest that the inhibitory effects of AsA possibly involve the (1) inhibition of the p38 MAPK-cytosolic phospholipase A2-arachidonic acid-TxA2-[Ca+ 2]i cascade, and (2) activation of NO/cyclic GMP, resulting in inhibition of phospholipase C. These results imply that Aristolochia fangchi treatment alone or in combination with other antiplatelet drugs, may result in alteration of hemostasis in vivo.

1 July 2012 in Archives of Gerontology and Geriatrics
Verified
Journal Article
Closed access
Ming Hsien LinMing Hsien Lin
Ming Hsien Lin
CLChien-Liang Liu
Chien-Liang Liu
LPLi-Ning Peng
Li-Ning Peng
YCYi-Tsun Chen
Yi-Tsun Chen
LCLiang-Kung Chen
Liang-Kung Chen

6 May 2011 in Journal of Clinical Gerontology and Geriatrics
Verified
Journal Article
Open access
PDF file
LPLi-Ning Peng
Li-Ning Peng
CLChien-Liang Liu
Chien-Liang Liu
Ming Hsien LinMing Hsien Lin
Ming Hsien Lin
SHShinn-Jang Hwang
Shinn-Jang Hwang
LCLiang-Kung Chen
Liang-Kung Chen
Background: Hypertension is common and often left undiagnosed in the elderly. The main purpose of this study was to evaluate the clinical characteristics of nondiabetic hypertensive older adults. Methods: Community-living older adults in Taipei City participating in annual health examinations were invited for study. Subjects with diabetes mellitus, whether treated or newly diagnosed, were excluded for further analysis. All participants were classified into three groups: normotension, untreated hypertension (UH), and treated hypertension (TH). Results: In total, 3244 subjects (mean age: 73.4 ± 5.4 years, 56.2% males) were enrolled. The prevalence of hypertension, chronic kidney disease (CKD), and left ventricular hypertrophy (LVH) was 52.9% (36.1% TH and 16.8% UH), 20.9%, and 6.2%, respectively. Compared with the normotension group, UH subjects were older (73.8 ± 5.5 years vs. 72.9 ± 5.6 years, p = 0.003); having higher body mass index (24.2 ± 3.4 kg/m2vs. 23.6 ± 3.4 kg/m2, p = 0.001), fasting glucose (101.7 ± 9.1 mg/dL vs. 100.5 ± 9.0 mg/dL, p = 0.007), total cholesterol (TC) (205.0 ± 37.8 mg/dL vs. 196.5 ± 36.4 mg/dL, p < 0.001), triglyceride (TG) (134.5 ± 84.9 mg/dL vs. 119.4 ± 77.0 mg/dL, p < 0.001); and higher prevalence of overt proteinuria (19.3% vs. 13.5%, p = 0.001), CKD (21.1% vs. 16.6%, p = 0.025), and LVH (8.1% vs. 3.8%, p < 0.001). However, the prevalence of overt proteinuria (19.3% vs. 21.1%, p = 0.378) and LVH (8.1% vs. 8.5%, p = 0.79) between UH and TH groups was similar. Adjusted for age, TC, TG, fasting plasma glucose, and the incidence of LVH, both UH [odds ratio (OR) = 1.30, 95% confidence interval (CI) = 1.01–1.66, p = 0.040] and TH (OR = 1.69, 95% CI = 1.39–2.05, p < 0.001) were significant risk factor for CKD. In addition, independent risk factors for CKD included age (OR = 1.07, 95% CI = 1.05–1.09, p < 0.001), body mass index (OR = 1.07, 95% CI = 1.04–1.10, p < 0.001), TC (OR = 1.003, 95% CI = 1.001–1.005, p = 0.021), TG (OR = 1.002, 95% CI = 1.001–1.003, p < 0.001), and hypertension (TH or UH) (OR = 1.44, 95% CI = 1.20–1.72, p < 0.001). Conclusion: In conclusion, risk of CKD existing along with blood pressure rises among nondiabetic older hypertensive adults, and hypertension (TH or UH) carries a significant risk of CKD after adjustment of other cardiovascular risk factors. Renal protection should be highlighted in the antihypertensive treatment strategy in older hypertensive patients.

25 December 2023 in Alzheimer's & Dementia
Verified
Journal Article
Open access
CLChien‐Liang Liu
Chien‐Liang Liu
CCChen-Han Chueh
Chen-Han Chueh
YTYi-Wen Tsai
Yi-Wen Tsai
SYSzu‐Nian Yang
Szu‐Nian Yang
Background: Early diagnosis of dementia has been considered an effective strategy to reduce the healthcare cost for dementia but not conclusive. Our aim is to examine the association between early diagnosis of dementia and healthcare utilization in the first psychiatric hospitalization for behavioral and psychological symptoms.Methods: This retrospective cohort study examined whether the diagnosis of dementia before index hospitalization affected healthcare management after the index hospitalization for 1972 elderly individuals between 2005 and 2015, using National Health Insurance claims data in Taiwan. Propensity scores, inverse probability of treatment weighting (IPTW), and regression analyses were used to adjust for confounding and examine the effect of early dementia diagnosis. The outcomes were chemical restraints, physical restraints, and healthcare utilization.Results: Among the 1,972 patients, 89.6% had an early diagnosis, and 10.4% had a delayed dementia diagnosis. The delayed dementia diagnosis group was younger and had less comorbidity. IPTW showed that the delayed diagnosis group received more chemical and physical restraints. The length of stay of index hospitalization in the delayed diagnosis group was 8 days longer than the early diagnosis group. Additionally, the delayed diagnosis group had significantly higher total medical expenses by NT$27,344 and higher total drug expenses by NT$1,912 than the early diagnosis group.Conclusion: An early diagnosis of dementia was associated with decreased use of physical and chemical restraints, shortened length of stay of acute hospitalization, and decreased overall healthcare costs in psychiatric hospital admissions compared with a delayed diagnosis.